会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明专利
    • PYRROLOAZEPINE DERIVATIVE
    • CA2093631A1
    • 1993-02-08
    • CA2093631
    • 1992-08-06
    • SUNTORY LTD
    • MIZUNO AKIRACHO HIDETSURAMIYA MIKIKOTATSUOKA TOSHIOISHIHARA TAKAFUMI
    • C07D487/04A61K31/55
    • (As modified by the Japanese Patent Office as an International Searching authority in view of the Applicant's comments on the Ab stract prepared by the International Searching Authority) This invention provides a pyrroloazepine derivative represented by the following formula (I): (I) wherein, when the bond indicated by the dashed line is present, Z1 represents H but, when the bond indicated by the dashed line is absent, Z1 represents H and Z2 represents OH or Z1 and Z2 are taken together to form O or a group NOR1, R1 representing H, an alkyl group or the like, R represents H, an alkyl group or the like; A represents an alkylene, alkenylene or alkynylene group with one of Hs being optionally substituted by OH; Y represents a group: or in which R2 and R3 individually represent H, an alkyl group or the like, R4 and R5 individually represent H or an alkyl group; B represents a carbonyl group, a ? sulfonyl group or the like; m stands for 1 or 2; n stands for 0 or 1, and D represents an alkoxy group, an aromatic heterocyclic ring or the like; a salt thereof; a preparation process thereof; and a therapeutic for circulatory diseases, said therapeutic containing as an active ingredient the pyrroloazepine derivative or the salt thereof.
    • 4. 发明专利
    • PYRROLOAZEPINE DERIVATIVE
    • CA2093631C
    • 2003-09-23
    • CA2093631
    • 1992-08-06
    • SUNTORY LTD
    • ISHIHARA TAKAFUMIMIZUNO AKIRACHO HIDETSURAMIYA MIKIKOTATSUOKA TOSHIO
    • C07D487/04A61K31/55
    • This invention provides a pyrroloazepine deriva- tive represented by the following formula (I): (see figure I) wherein, when the bond indicated by the dashed line is present, Z1 represents H but, when the bond indicated by the dashed line is absent, Z1 represents H and Z2 represents OH or Z1 and Z2 are taken together to form O or a group NOR1, R1 representing H, an alkyl group or the like, R represents H, an alkyl group or the like; A represents an alkylene, alkenyl.ene or alkynylene group with one of Hs being optionally substituted by OH: Y represents a group: (see figure II, III) in which R2 and R3 individually represent H, an alkyl group or the like, R4 and R5 individually represent H or an alkyl group; B represents a carbonyl group, a sulfonyl group or the like: m stands for 1 or 2; n stands for 0 or 1; and D represents an alkoxy group, an aromatic heterocyclic ring or the like; a salt thereof; a preparation process thereof; and a therapeutic for circulatory diseases, said therapeutic containing as an active ingredient the pyrroloazepine derivative or the salt thereof.